Curran Simpson, Regenxbio CEO

Re­genxbio shares first da­ta show­ing Duchenne gene ther­a­py im­proves mus­cle func­tion

Re­genxbio said its gene ther­a­py im­proved mus­cle func­tion in a hand­ful of boys with Duchenne mus­cu­lar dy­s­tro­phy across two dos­es.

The gene ther­a­py com­pa­ny said …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.